|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/713 | (2006.01) |
| A61P 31/20 | (2006.01) | ||
| A61K 39/42 | (2006.01) | ||
| A61K 31/52 | (2006.01) | ||
| A61K 31/67 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K 16/08 | (2006.01) |
| (11) | Number of the document | 4285929 |
| (13) | Kind of document | T |
| (96) | European patent application number | 23190149.7 |
| Date of filing the European patent application | 2019-12-19 | |
| (97) | Date of publication of the European application | 2023-12-06 |
| (45) | Date of publication and mention of the grant of the patent | 2025-10-08 |
| (46) | Date of publication of the claims translation | 2026-01-12 |
| (30) | Number | Date | Country code |
| 201862782896 P | 2018-12-20 | US |
| (72) |
BAKARDJIEV, ANNA , US
PANG, PHILLIP , US
CORTI, DAVIDE , CH
|
| (73) |
Humabs Biomed SA ,
Via dei Gaggini, 3, 6500 Bellinzona,
CH
VIR Biotechnology, Inc. , 1800 Owens Street Suite 900, San Francisco, CA 94158, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kompleksinė HBV terapija |
| COMBINATION HBV THERAPY |
| Payment date | Validity (years) | Amount | |
| 2025-12-02 | 7 | 162.00 EUR |
| 2026-12-19 |